Toshiaki Tsujino

630 total citations
17 papers, 528 citations indexed

About

Toshiaki Tsujino is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, Toshiaki Tsujino has authored 17 papers receiving a total of 528 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 5 papers in Organic Chemistry and 3 papers in Pharmacology. Recurrent topics in Toshiaki Tsujino's work include Asymmetric Synthesis and Catalysis (5 papers), Synthetic Organic Chemistry Methods (3 papers) and Microbial Natural Products and Biosynthesis (2 papers). Toshiaki Tsujino is often cited by papers focused on Asymmetric Synthesis and Catalysis (5 papers), Synthetic Organic Chemistry Methods (3 papers) and Microbial Natural Products and Biosynthesis (2 papers). Toshiaki Tsujino collaborates with scholars based in Japan. Toshiaki Tsujino's co-authors include Shuji Akai, Tadaatsu Naka, Yasuyuki Kita, Ichiro Takemasa, Masataka Ikeda, Chew Yee Ngan, Mitsugu Sekimoto, Morito Monden, N. Matsuura and Iwao Seshimo and has published in prestigious journals such as Nucleic Acids Research, British Journal of Cancer and Diabetologia.

In The Last Decade

Toshiaki Tsujino

16 papers receiving 521 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Toshiaki Tsujino Japan 12 225 188 93 74 49 17 528
Yuichi Koga Japan 12 386 1.7× 259 1.4× 170 1.8× 105 1.4× 28 0.6× 22 807
Zhouling Xie China 16 277 1.2× 158 0.8× 141 1.5× 42 0.6× 49 1.0× 46 643
Ingo V. Hartung Germany 14 315 1.4× 477 2.5× 70 0.8× 56 0.8× 51 1.0× 36 906
Yuyan Bao China 12 273 1.2× 111 0.6× 56 0.6× 99 1.3× 45 0.9× 22 579
Andreas Böttcher Germany 10 207 0.9× 80 0.4× 179 1.9× 45 0.6× 54 1.1× 18 533
Robert A. Mantei United States 15 308 1.4× 258 1.4× 111 1.2× 95 1.3× 61 1.2× 24 621
Stuart B. Rosenblum United States 13 173 0.8× 326 1.7× 204 2.2× 64 0.9× 23 0.5× 23 725
Laura Dal Bo Italy 16 368 1.6× 220 1.2× 201 2.2× 59 0.8× 55 1.1× 20 724
Patricia D. Pelton United States 19 427 1.9× 201 1.1× 55 0.6× 60 0.8× 28 0.6× 24 855
Carl P. Ciosek United States 18 545 2.4× 210 1.1× 126 1.4× 97 1.3× 38 0.8× 23 931

Countries citing papers authored by Toshiaki Tsujino

Since Specialization
Citations

This map shows the geographic impact of Toshiaki Tsujino's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Toshiaki Tsujino with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Toshiaki Tsujino more than expected).

Fields of papers citing papers by Toshiaki Tsujino

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Toshiaki Tsujino. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Toshiaki Tsujino. The network helps show where Toshiaki Tsujino may publish in the future.

Co-authorship network of co-authors of Toshiaki Tsujino

This figure shows the co-authorship network connecting the top 25 collaborators of Toshiaki Tsujino. A scholar is included among the top collaborators of Toshiaki Tsujino based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Toshiaki Tsujino. Toshiaki Tsujino is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Ando, Yuichi, Sachi Morita, Tomoya Shimokata, et al.. (2022). A rapid and durable response to larotrectinib in a patient with NTRK fusion-positive secretory carcinoma originating from the external auditory canal. International Cancer Conference Journal. 11(4). 242–246.
2.
Satô, Yoshiyuki, T Sugimoto, Kaori Kamijo, et al.. (2009). Imidazopyridine derivatives as potent and selective Polo-like kinase (PLK) inhibitors. Bioorganic & Medicinal Chemistry Letters. 19(16). 4673–4678. 46 indexed citations
3.
Kameda, Minoru, Kensuke Kobayashi, Hiroshi Miyazoe, et al.. (2009). Optimization of a series of 2,4-diaminopyridines as neuropeptide Y Y1 receptor antagonists with reduced hERG activity. Bioorganic & Medicinal Chemistry Letters. 19(15). 4325–4329. 8 indexed citations
4.
Ando, Makoto, Kensuke Kobayashi, Hiroshi Miyazoe, et al.. (2009). Design, synthesis and evaluation of a novel cyclohexanamine class of neuropeptide Y Y1 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 19(16). 4781–4785. 9 indexed citations
5.
Tsujino, Toshiaki, et al.. (2008). Detection of organic free radicals in irradiated Foeniculi fructus by electron spin resonance spectroscopy. Journal of Natural Medicines. 63(1). 28–31. 18 indexed citations
6.
Ngan, Chew Yee, Hirokazu Yamamoto, Iwao Seshimo, et al.. (2007). Quantitative evaluation of vimentin expression in tumour stroma of colorectal cancer. British Journal of Cancer. 96(6). 986–992. 127 indexed citations
7.
Takayama, Osamu, Hirofumi Yamamoto, Bazarragchaa Damdinsuren, et al.. (2006). Expression of PPARδ in multistage carcinogenesis of the colorectum: implications of malignant cancer morphology. British Journal of Cancer. 95(7). 889–895. 62 indexed citations
8.
Takeuchi, Kosei, et al.. (2006). Uterine bizarre epithelioid lipoleiomyoma with a myxoid stroma.. PubMed. 27(3). 273–4. 2 indexed citations
9.
Akai, Shuji, Toshiaki Tsujino, Nobuhisa Fukuda, et al.. (2005). Asymmetric Total Synthesis of Fredericamycin A: An Intramolecular Cycloaddition Pathway. Chemistry - A European Journal. 11(21). 6286–6297. 22 indexed citations
11.
Yamasaki, Yoshimitsu, Shohei Yoshida, Yoshitaka Kajimoto, et al.. (2002). A phosphodiesterase inhibitor, cilostazol, prevents the onset of silent brain infarction in Japanese subjects with Type II diabetes. Diabetologia. 45(2). 188–194. 66 indexed citations
12.
Akai, Shuji, Toshiaki Tsujino, Nobuhisa Fukuda, et al.. (2001). Enantiodivergent Synthesis of Either Enantiomer of ABCDE-Ring Analogue of Antitumor Antibiotic Fredericamycin A via Intramolecular [4 + 2] Cycloaddition Approach. Organic Letters. 3(25). 4015–4018. 19 indexed citations
13.
Akai, Shuji, Toshiaki Tsujino, Tadaatsu Naka, Kouichi Tanimoto, & Yasuyuki Kita. (2001). Lipase-catalyzed enantioselective desymmetrization of prochiral 3,3-bis(hydroxymethyl)oxindoles. Tetrahedron Letters. 42(41). 7315–7317. 12 indexed citations
14.
Akai, Shuji, Tadaatsu Naka, Tetsuya Theodore. Fujita, et al.. (2001). Efficient Lipase-Catalyzed Enantioselective Desymmetrization of Prochiral 2,2-Disubstituted 1,3-Propanediols and Meso 1,2-Diols Using 1-Ethoxyvinyl 2-Furoate. The Journal of Organic Chemistry. 67(2). 411–419. 38 indexed citations
15.
Iio, Kiyosei, Kenichi Kawaguchi, Nobuhisa Fukuda, et al.. (2000). Total Synthesis of the Antitumor Antibiotic (±)-Fredericamycin A by a Linear Approach. Chemistry - A European Journal. 6(21). 3897–3905. 31 indexed citations
16.
Komatsu, Yasuo, Toshiaki Tsujino, Tetsuya Suzuki, Osamu Nikaido, & Eiko Ohtsuka. (1997). Antigen Structural Requirements for Recognition by a Cyclobutane Thymine Dimer-Specific Monoclonal Antibody. Nucleic Acids Research. 25(19). 3889–3894. 13 indexed citations
17.
Yamasaki, Yoshimitsu, et al.. (1994). Selective alpha 1-adrenergic inhibition improves decrease glucose disposal in patients with essential hypertension.. PubMed. 8(8). 555–8. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026